These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 489517)

  • 1. Double-blind study of thioridazine and haloperidol in geriatric patients with a psychosis associated with organic brain syndrome.
    Cowley LM; Glen RS
    J Clin Psychiatry; 1979 Oct; 40(10):411-9. PubMed ID: 489517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol versus thioridazine in the treatment of behavioral symptoms in senile dementia of the Alzheimer's type: preliminary findings.
    Steele C; Lucas MJ; Tune L
    J Clin Psychiatry; 1986 Jun; 47(6):310-2. PubMed ID: 3711028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter study comparing thioridazine with diazepam and placebo in elderly, nonpsychotic patients with emotional and behavioral disorders.
    Stotsky B
    Clin Ther; 1984; 6(4):546-59. PubMed ID: 6380725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind comparison of haloperidol (Haldol) and thioridazine (Mellaril) in outpatient children.
    Claghorn JL
    Curr Ther Res Clin Exp; 1972 Dec; 14(12):785-9. PubMed ID: 4629817
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of behavioral symptoms in disturbed elderly patients: comparison of trifluoperazine and haloperidol.
    Lovett WC; Stokes DK; Taylor LB; Young ML; Free SM; Phelan DG
    J Clin Psychiatry; 1987 Jun; 48(6):234-6. PubMed ID: 3294815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
    Abuzzahab FS; Zimmerman RL
    J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haloperidol versus thioridazine for hospitalized psychogeriatric patients: double-blind study.
    Tsuang MM; Lu LM; Stotsky BA; Cole JO
    J Am Geriatr Soc; 1971 Jul; 19(7):593-600. PubMed ID: 4937658
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind comparison of the effects of haloperidol and cis(Z)-clopenthixol in senile dementia.
    Götestam KG; Ljunghall S; Olsson B
    Acta Psychiatr Scand Suppl; 1981; 294():46-53. PubMed ID: 7041519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic treatment of oligophrenic patients. A double-blind clinical multicentre trial of cis(Z)-clopenthixol and haloperidol.
    Karsten D; Kivimäki T; Linna SL; Pollari L; Turunen S
    Acta Psychiatr Scand Suppl; 1981; 294():39-45. PubMed ID: 7041518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial.
    Akhondzadeh S; Milajerdi MR; Amini H; Tehrani-Doost M
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):485-9. PubMed ID: 17042886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open assessment of the safety and efficacy of thioridazine in the treatment of patients with borderline personality disorder.
    Teicher MH; Glod CA; Aaronson ST; Gunter PA; Schatzberg AF; Cole JO
    Psychopharmacol Bull; 1989; 25(4):535-49. PubMed ID: 2631134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic treatment of HIV-associated psychosis. HNRC group.
    Sewell DD; Jeste DV; McAdams LA; Bailey A; Harris MJ; Atkinson JH; Chandler JL; McCutchan JA; Grant I
    Neuropsychopharmacology; 1994 Jul; 10(4):223-9. PubMed ID: 7945732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of tiospirone vs. haloperidol and thioridazine in a double-blind, placebo-controlled trial.
    Borison RL; Sinha D; Haverstock S; McLarnon MC; Diamond BI
    Psychopharmacol Bull; 1989; 25(2):190-3. PubMed ID: 2574893
    [No Abstract]   [Full Text] [Related]  

  • 14. Amoxapine as an antipsychotic: comparative study versus haloperidol.
    Chaudhry IB; Husain N; Khan S; Badshah S; Deakin B; Kapur S
    J Clin Psychopharmacol; 2007 Dec; 27(6):575-81. PubMed ID: 18004123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic drugs in the management of behavioral symptoms of Alzheimer's disease.
    Tune LE; Steele C; Cooper T
    Psychiatr Clin North Am; 1991 Jun; 14(2):353-73. PubMed ID: 1676507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical neuroleptics in acute schizophrenia: a double-blind comparative study of remoxipride and haloperidol.
    den Boer JA; Westenberg HG
    Psychopharmacol Bull; 1990; 26(1):99-107. PubMed ID: 1973547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal effective dose and relapse--double-blind trial: haloperidol decanoate vs. placebo.
    Eklund K; Forsman A
    Clin Neuropharmacol; 1991; 14 Suppl 2():S7-12; discussion S12-5. PubMed ID: 1684310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of hostile, suspicious patients. Trifluoperazine versus haloperidol.
    O'Brien CP; DiGiacomo JN; Webb W
    Dis Nerv Syst; 1974 Feb; 35(2):75-8. PubMed ID: 17894044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.